Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04256213
Title COL Immunotherapy Before Radiochimio + Ipilimumab (COLIBRI)
Recruitment Active, not recruiting
Gender female
Phase Phase 0
Variant Requirements No
Sponsors ARCAGY/ GINECO GROUP
Indications

cervical squamous cell carcinoma

Therapies

Ipilimumab + Nivolumab

Age Groups: adult
Covered Countries FRA


No variant requirements are available.